Premium
Glycogenic hepatopathy is an under‐recognised cause of hepatomegaly and elevated liver transaminases in type 1 diabetes mellitus
Author(s) -
Irani N. R.,
Venugopal K.,
Kontorinis N.,
Lee M.,
Sinniah R.,
Bates T. R.
Publication year - 2015
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12807
Subject(s) - medicine , elevated transaminases , liver biopsy , complication , diabetes mellitus , gastroenterology , type 1 diabetes , type 2 diabetes mellitus , endocrinology , biopsy
Glycogenic hepatopathy ( GH ) is an under‐recognised complication of type 1 diabetes mellitus ( T1DM ) not controlled to target resulting in hepatomegaly and elevated liver transaminases. We report the case of a 19‐year‐old man with T1DM not controlled to target who presented with abdominal pain, hepatomegaly and deranged liver transaminases. He was subsequently diagnosed with GH on liver biopsy, with the mainstay of treatment being reduction in caloric intake and insulin.